Javascript must be enabled for this website to work.

#script { display:none; } #noScript{ width: 350px; height: 175px; text-align: center; background: white; padding: 35px; display: block; margin-top: -87px; top: 50%; position: absolute; border-bottom: 1px solid #c2c2c2; border-left: 1px solid #e6e6e6; border-right: 1px solid #e6e6e6; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; margin-left: 50%; left: -175px; } #noScript img{width:100%;} body{background:#f7f7f7;}

Sacre bleu, that’s a nice hello

Monday, 23 Feb 2015

French pharmaceutical company Sanofi has come under fire this week over a welcome bonus for its new CEO. Oliver Brandicourt will collect a €2 million signing up bonus. He’s eligible for up to €2 million more in January 2016 (assuming he is still in the job) and up to €4.2 million for performance related bonus. That’s on top of his €1.2 million base salary and shares and options. That big fat cheque equates to around $5.8 million Australian dollars.

Already a member?

Login to keep reading.

Email me a login link

Not a member yet?

Join now to stay up to date with the latest clinical and medico-political news relevant to your specialty. the limbic is intended for practicing healthcare professionals only.

title*

first name*

last name*

country*

Postcode where you practice*

Email*

password* Forgot password?

Password must contain at least 8 characters including 1 letter and 1 number.

ahpra number* Find my AHPRA number

primary area of interest*

Our newsletter is a quick and easy to read summary of the latest clinical and medico-political news relevant to your specialty. It may contain advertising and educational or promotional material from carefully selected industry partners including pharmaceutical companies, government agencies and not-for-profit organisations. Your details will not be shared with any other party.

I would like to receive the limbic newsletter

I have read and agree to the limbic Terms and Conditions & Privacy Policy

Cancel